Literature DB >> 16061665

Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer.

Michele A Gauger1, Aziz Sancar.   

Abstract

It has been reported that disruption of the circadian clock may lead to increased risk of breast cancer in humans and to a high rate or ionizing radiation-induced tumors and mortality in mice. Cryptochrome 1 and cryptochrome 2 proteins are core components of the mammalian circadian clock and mice mutated in both genes are arrhythmic. We tested Cry1-/- Cry2-/- mice and fibroblasts derived from these mice for radiation-induced cancer and killing and DNA damage checkpoints and killing, respectively. We find that the mutant mice are indistinguishable from the wild-type controls with respect to radiation-induced morbidity and mortality. Similarly, the Cry1-/- Cry2-/-mutant fibroblasts are indistinguishable from the wild-type controls with respect to their sensitivity to ionizing radiation and UV radiation and ionizing radiation-induced DNA damage checkpoint response. Our data suggest that disruption of the circadian clock in itself does not compromise mammalian DNA repair and DNA damage checkpoints and does not predispose mice to spontaneous and ionizing radiation-induced cancers. We conclude that the effect of circadian clock disruption on cellular response to DNA damage and cancer predisposition in mice may depend on the mechanism by which the clock is disrupted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061665     DOI: 10.1158/0008-5472.CAN-05-1119

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  68 in total

1.  The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling.

Authors:  Aaron E Hoffman; Tongzhang Zheng; Chun-Hui Yi; Richard G Stevens; Yue Ba; Yawei Zhang; Derek Leaderer; Theodore Holford; Johnni Hansen; Yong Zhu
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-16

2.  Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology.

Authors:  Lynne V Abruzzo; Lynn L Barron; Keith Anderson; Rachel J Newman; William G Wierda; Susan O'brien; Alessandra Ferrajoli; Madan Luthra; Sameer Talwalkar; Rajyalakshmi Luthra; Dan Jones; Michael J Keating; Kevin R Coombes
Journal:  J Mol Diagn       Date:  2007-08-09       Impact factor: 5.568

Review 3.  Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment.

Authors:  Gabriele Sulli; Michael Tun Yin Lam; Satchidananda Panda
Journal:  Trends Cancer       Date:  2019-08-03

4.  Evaluation of melatonin and AFMK levels in women with breast cancer.

Authors:  Tialfi Bergamin de Castro; Newton Antônio Bordin-Junior; Eduardo Alves de Almeida; Debora Aparecida Pires de Campos Zuccari
Journal:  Endocrine       Date:  2018-05-24       Impact factor: 3.633

5.  Functional polymorphisms of circadian negative feedback regulation genes are associated with clinical outcome in hepatocellular carcinoma patients receiving radical resection.

Authors:  Zhaohui Zhang; Fei Ma; Feng Zhou; Yibing Chen; Xiaoyan Wang; Hongxin Zhang; Yong Zhu; Jianwei Bi; Yiguan Zhang
Journal:  Med Oncol       Date:  2014-10-26       Impact factor: 3.064

6.  Cryptochrome-1 expression: a new prognostic marker in B-cell chronic lymphocytic leukemia.

Authors:  Eloisa Jantus Lewintre; Cristina Reinoso Martín; Carlos García Ballesteros; David Montaner; Rosa Farrás Rivera; José Ramón Mayans; Javier García-Conde
Journal:  Haematologica       Date:  2009-02       Impact factor: 9.941

7.  Loss of cryptochrome reduces cancer risk in p53 mutant mice.

Authors:  Nuri Ozturk; Jin Hyup Lee; Shobhan Gaddameedhi; Aziz Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

8.  Comparative photochemistry of animal type 1 and type 4 cryptochromes.

Authors:  Nuri Ozturk; Christopher P Selby; Sang-Hun Song; Rui Ye; Chuang Tan; Ya-Ting Kao; Dongping Zhong; Aziz Sancar
Journal:  Biochemistry       Date:  2009-09-15       Impact factor: 3.162

9.  Phenotypic effects of the circadian gene Cryptochrome 2 on cancer-related pathways.

Authors:  Aaron E Hoffman; Tongzhang Zheng; Yue Ba; Richard G Stevens; Chun-Hui Yi; Derek Leaderer; Yong Zhu
Journal:  BMC Cancer       Date:  2010-03-24       Impact factor: 4.430

10.  Circadian rhythm and its role in malignancy.

Authors:  Sobia Rana; Saqib Mahmood
Journal:  J Circadian Rhythms       Date:  2010-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.